Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Metastases From Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02978404
What this trial is testing

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Who this might be right for
Clear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 26
Testing effectiveness (Phase 2)Looking for participantsNCT07130786
What this trial is testing

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Who this might be right for
SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more
Ayal A. Aizer, MD 150
Testing effectiveness (Phase 2)Study completedNCT00080938
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Eastern Cooperative Oncology Group 26
Early research (Phase 1)Active Not RecruitingNCT02589522
What this trial is testing

Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors

Who this might be right for
Metastatic Lung Neuroendocrine NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+4 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Ended earlyNCT00892801
What this trial is testing

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Vanderbilt-Ingram Cancer Center 5
Testing effectiveness (Phase 2)WithdrawnNCT04889066
What this trial is testing

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Brain Metastases from Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT00390806
What this trial is testing

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 472
Testing effectiveness (Phase 2)Looking for participantsNCT06702826
What this trial is testing

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain MetastasesStereotactic Radiation+1 more
Rongrong Zhou 20
Testing effectiveness (Phase 2)WithdrawnNCT02014545
What this trial is testing

Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789444
What this trial is testing

Sacituzumab Tirumotecan（Sac-TMT） and Brain Radotherapy for EGFR+ NSCLC With Brain Mets

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases From Non-small Cell Lung Cancer (NSCLC)EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer
Xiaorong Dong 53
Large-scale testing (Phase 3)UnknownNCT02972333
What this trial is testing

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Who this might be right for
EGFR-TKI Resistant MutationNonsmall Cell Lung CancerAZD9291+1 more
Shandong Cancer Hospital and Institute 150
Early research (Phase 1)Study completedNCT03535363
What this trial is testing

Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC

Who this might be right for
NSCLCNon-small Cell Lung Cancer
Case Comprehensive Cancer Center 6
Not applicableNot Yet RecruitingNCT06716775
What this trial is testing

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

Who this might be right for
NSCLC Brain Metastasis
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 200
Testing effectiveness (Phase 2)Study completedNCT00076856
What this trial is testing

Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm MetastasisBrain Neoplasms
Merck Sharp & Dohme LLC 95
Testing effectiveness (Phase 2)Looking for participantsNCT06822543
What this trial is testing

A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Who this might be right for
Lung CancerNon Small Cell Lung CancerBrain Metastases
Latin American Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Looking for participantsNCT06974370
What this trial is testing

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

Who this might be right for
Brain Metastases, AdultBrain Metastases From Non-small Cell Lung Cancer (NSCLC)
University of Vermont Medical Center 45
Testing effectiveness (Phase 2)Ended earlyNCT00266812
What this trial is testing

Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789912
What this trial is testing

BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies

Who this might be right for
Leptomeningeal MetastasisBreast CancerLung Cancer (NSCLC)
University of Miami 40
Early research (Phase 1)UnknownNCT03638765
What this trial is testing

Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer

Who this might be right for
Brain MetastasesLung Cancer MetastaticBreast Cancer Metastatic
Northwest Biotherapeutics 24
Testing effectiveness (Phase 2)Study completedNCT01514877
What this trial is testing

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Zhejiang Cancer Hospital 20
Next Page